Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000902664-14-003127
Filing Date
2014-07-14
Accepted
2014-07-14 15:16:50
Documents
1
Effectiveness Date
2014-07-14
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11202
  Complete submission text file 0000902664-14-003127.txt   12345
Mailing Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022 212-739-6400
OrbiMed Global Healthcare Fund, L.P. (Filer) CIK: 0001613540 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-220964 | Film No.: 14973583